1. Hippo signaling in cancer: regulatory mechanisms and therapeutic strategies
    Zhao Huang et al, 2023, Australian Journal of Chemistry CrossRef
  2. Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
    Peter Julius et al, 2023, Frontiers in Oncology CrossRef
  3. The Hippo signaling pathway in leukemia: function, interaction, and carcinogenesis
    Negar Noorbakhsh et al, 2021, Cancer Cell International CrossRef
  4. A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment
    Jenny Shim et al, 2021, Cancers CrossRef
  5. Mechanical Cues, E-Cadherin Expression and Cell “Sociality” Are Crucial Crossroads in Determining Pancreatic Ductal Adenocarcinoma Cells Behavior
    Francesca Bianchi et al, 2022, Cells CrossRef
  6. YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma
    Yi-Zih Kuo et al, 2022, Cellular Oncology CrossRef
  7. Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum
    Jose Francisco Islas et al, 2022, Cancers CrossRef
  8. YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma
    Xue-Wei Wang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
  9. Yes-associated protein gene overexpression regulated by β-catenin promotes gastric cancer cell tumorigenesis
    Tianzhu Qiu et al, 2022, Technology and Health Care CrossRef
  10. Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers
    Yating Xu et al, 2023, Frontiers in Immunology CrossRef
  11. Yes-Associated Protein Is Required for ZO-1-Mediated Tight-Junction Integrity and Cell Migration in E-Cadherin-Restored AGS Gastric Cancer Cells
    Seon-Young Kim et al, 2021, Biomedicines CrossRef
  12. C12orf59 Promotes Esophageal Squamous Cell Carcinoma Progression via YAP-Mediated Epithelial-Mesenchymal Transition
    Chunhua Xu et al, 2022, Frontiers in Oncology CrossRef